Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Developmental Pharmacology and Therapeutics|January 1, 1989
Effect of chronic maternal drug addiction on placental drug metabolismE M Ostrea, T Porter, J Balun, et al.
American Journal of Obstetrics and Gynecology|October 1, 1989
Cordocentesis in the diagnosis of intrauterine starvationD L Economides, K H Nicolaides, W A Gahl, et al.
Alcoholism, Clinical and Experimental Research|October 1, 1994
Screening for pregnancy risk-drinkingM Russell, S S Martier, R J Sokol, et al.
American Journal of Perinatology|October 1, 1987
Does intravenous ritodrine therapy cause capillary endothelial damage?G Goyert, R Bhatia, C Schubert, et al.
American Journal of Obstetrics and Gynecology|December 1, 1993
Thrombosis and hormone replacement therapy in postmenopausal womenA A Saleh, L G Dorey, M P Dombrowski, et al.
American Journal of Obstetrics and Gynecology|October 1, 1996
The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units NetworkR L Goldenberg, J D Iams, M Miodovnik, et al.
American Journal of Obstetrics and Gynecology|March 30, 2000
The preterm prediction study: cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units NetworkR L Goldenberg, W W Andrews, R L Guerrant, et al.
Blood Advances|September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignanciesAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid LeukemiaAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Blood Advances|March 12, 2024
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tractZachariah DeFilipp, Ashish V Damania, Haesook T Kim, et al.
Pageof 2